AXL and neoplasm: Our results showed that R428 at a low dose (10 mg·kg−1), which was selected based on a published study (Holland et al., 2010), had no significant effect on tumor growth (Fig. 6A,B), although a significant reduction in p‐AXL (Y779) protein level was observed (P < 0.01, Fig. S7).